Literature DB >> 26152816

Recent research on bioactive xanthones from natural medicine: Garcinia hanburyi.

Buyun Jia1, Shanshan Li, Xuerui Hu, Guangyu Zhu, Weidong Chen.   

Abstract

Garcinia hanburyi, a tropical plant found in south Asia, has a special long history in the development of both medicine and art. This review mainly focuses on the pharmacy research of the bioactive compounds from the plant in recent years. Preparative and analysis separation methods were introduced. Moreover, the chemical structure of the isolated compounds was included. The studies of biological activities of the caged xanthones from the plant, including antitumor, anti-HIV-1, antibacterial, and neurotrophic activities, were reviewed in detail. Furthermore, the mechanisms of its antitumor activity were also reviewed. As mentioned above, some of the xanthones from G. hanburyi can be promising drug candidates, which is worth studying. However, we still need much evidence to prove their efficacy and safety. So, further research is critical for the future application of xanthones from G. hanburyi.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26152816      PMCID: PMC4508296          DOI: 10.1208/s12249-015-0339-4

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  105 in total

1.  Gambogic acid deactivates cytosolic and mitochondrial thioredoxins by covalent binding to the functional domain.

Authors:  Jing Yang; Chenglin Li; Li Ding; Qinglong Guo; Qidong You; Shaohong Jin
Journal:  J Nat Prod       Date:  2012-06-04       Impact factor: 4.050

2.  Gambogic acid inhibits Hsp90 and deregulates TNF-α/NF-κB in HeLa cells.

Authors:  Lianru Zhang; Yuting Yi; Junjie Chen; Yifei Sun; Qiuju Guo; Zhonghui Zheng; Siyang Song
Journal:  Biochem Biophys Res Commun       Date:  2010-11-11       Impact factor: 3.575

3.  Cytotoxic and anti-HIV-1 caged xanthones from the resin and fruits of Garcinia hanburyi.

Authors:  Vichai Reutrakul; Natthinee Anantachoke; Manat Pohmakotr; Thaworn Jaipetch; Samaisukh Sophasan; Chalobon Yoosook; Jittra Kasisit; Chanita Napaswat; Thawatchai Santisuk; Patoomratana Tuchinda
Journal:  Planta Med       Date:  2006-11-21       Impact factor: 3.352

4.  Gambogic acid inhibits STAT3 phosphorylation through activation of protein tyrosine phosphatase SHP-1: potential role in proliferation and apoptosis.

Authors:  Sahdeo Prasad; Manoj K Pandey; Vivek R Yadav; Bharat B Aggarwal
Journal:  Cancer Prev Res (Phila)       Date:  2011-04-13

5.  Studies on gambogic acid (IV): Exploring structure-activity relationship with IκB kinase-beta (IKKβ).

Authors:  Haopeng Sun; Feihong Chen; Xiaojian Wang; Zongliang Liu; Qian Yang; Xiaojin Zhang; Jia Zhu; Lei Qiang; Qinglong Guo; Qidong You
Journal:  Eur J Med Chem       Date:  2012-03-03       Impact factor: 6.514

6.  Studies on chemical structure modification and biology of a natural product, gambogic acid (I): Synthesis and biological evaluation of oxidized analogues of gambogic acid.

Authors:  Jinxin Wang; Li Zhao; Yang Hu; Qinglong Guo; Lei Zhang; Xiaojian Wang; Nianguang Li; Qidong You
Journal:  Eur J Med Chem       Date:  2008-10-07       Impact factor: 6.514

7.  Gambogic acid is an antagonist of antiapoptotic Bcl-2 family proteins.

Authors:  Dayong Zhai; Chaofang Jin; Chung-Wai Shiau; Shinichi Kitada; Arnold C Satterthwait; John C Reed
Journal:  Mol Cancer Ther       Date:  2008-06       Impact factor: 6.261

8.  Gambogic acid induces apoptosis and regulates expressions of Bax and Bcl-2 protein in human gastric carcinoma MGC-803 cells.

Authors:  Li Zhao; Qing-Long Guo; Qi-Dong You; Zhao-Qiu Wu; Hong-Yan Gu
Journal:  Biol Pharm Bull       Date:  2004-07       Impact factor: 2.233

9.  Effects of gambogic acid on the regulation of nucleoporin Nup88 in U937 cells.

Authors:  Wenxiu Shu; Yan Chen; Jing He; Guohui Cui
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2007-08

10.  Microtubule depolymerization and phosphorylation of c-Jun N-terminal kinase-1 and p38 were involved in gambogic acid induced cell cycle arrest and apoptosis in human breast carcinoma MCF-7 cells.

Authors:  Jing Chen; Hong-Yan Gu; Na Lu; Yong Yang; Wei Liu; Qi Qi; Jing-Jing Rong; Xiao-Tang Wang; Qi-Dong You; Qing-Long Guo
Journal:  Life Sci       Date:  2008-05-16       Impact factor: 5.037

View more
  5 in total

1.  Potential Anticancer Agents Characterized from Selected Tropical Plants.

Authors:  Yulin Ren; Esperanza J Carcache de Blanco; James R Fuchs; Djaja D Soejarto; Joanna E Burdette; Steven M Swanson; A Douglas Kinghorn
Journal:  J Nat Prod       Date:  2019-03-04       Impact factor: 4.050

2.  Mangostanaxanthones III and IV: advanced glycation end-product inhibitors from the pericarp of Garcinia mangostana.

Authors:  Hossam M Abdallah; Hany M El-Bassossy; Gamal A Mohamed; Ali M El-Halawany; Khalid Z Alshali; Zainy M Banjar
Journal:  J Nat Med       Date:  2016-10-13       Impact factor: 2.343

3.  Effect of Gambogenic Acid on Cytochrome P450 1A2, 2B1 and 2E1, and Constitutive Androstane Receptor in Rats.

Authors:  Jing Sun; Xiaozhu Tang; Qianqian Xu; Tao Ge; Daiyin Peng; Weidong Chen
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2018-12       Impact factor: 2.441

4.  Synergistic Effect of 1,3,6-Trihydroxy-4,5,7-Trichloroxanthone in Combination with Doxorubicin on B-Cell Lymphoma Cells and Its Mechanism of Action Through Molecular Docking.

Authors:  Isnatin Miladiyah; Emmy Yuanita; Satyo Nuryadi; Jumina Jumina; Sofia Mubarika Haryana; Mustofa Mustofa
Journal:  Curr Ther Res Clin Exp       Date:  2020-01-30

5.  Gambogic amide inhibits angiogenesis by suppressing VEGF/VEGFR2 in endothelial cells in a TrkA-independent manner.

Authors:  Tongtong Sui; Bojun Qiu; Jiaorong Qu; Yuxin Wang; Kunnian Ran; Wei Han; Xiaozhong Peng
Journal:  Pharm Biol       Date:  2021-12       Impact factor: 3.503

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.